UKL-11423-48604
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 151 / PA
- Registered
- 2020-12-30
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-30
Registered in v-safe
-
2020-12-30
Dose 1 — Moderna
- 2020-12-30
-
2020-12-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · NauseaAdult check-in
- 2021-01-01
- 2021-01-02
- 2021-01-03
- 2021-01-06
- 2021-01-13
- 2021-01-20
-
2021-01-27
Dose 2 — Moderna
- 2021-01-27
-
2021-01-28
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-29
- 2021-01-30
- 2021-01-31
- 2021-02-01
- 2021-02-02
- 2021-02-03
- 2021-02-10
- 2021-02-19
- 2021-02-24
- 2021-03-03
- 2021-03-10
- 2021-04-28
-
2021-07-28
Survey response — 6 months, dose 2MedDRA: Gestational hypertension, Nephrolithiasis — Feeling: GoodFree text: Kidney stones, gestational hypertensionMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-01-28
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-30 | Moderna | |
| 2 | 2021-01-27 | Moderna |
Free text
Release 9 — 6 months, dose 2
Symptoms: Kidney stones, gestational hypertension
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Gestational hypertension | ✓ | · | ✓ |
| SD | Nephrolithiasis | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release